Advertisement
rahul kakkad

Rahul Kakkad

Innovation in the Lifesciences sector has a high lead time and is also heavily dependent on capital intensive R&D.

Budget 2022: Would it prove to be an immunity booster for Lifesciences sector?

by Rahul Kakkad |Jan 30, 2022

Increased budgetary allocations, promoting universal healthcare, medical tourism and Digital health ecosystem, etc. could provide the Lifesciences sector with the required centre stage.